Sanku Mallik Selected Research

Sanku Mallik Research Topics

Disease

34	Neoplasms (Cancer) 11/2023 - 10/2004
16	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2012
9	Hypoxia (Hypoxemia) 11/2023 - 01/2016
5	Breast Neoplasms (Breast Cancer) 10/2021 - 12/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 09/2009
2	Triple Negative Breast Neoplasms 01/2022 - 09/2021
2	Neoplasm Metastasis (Metastasis) 01/2016 - 09/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024
1	Circulating Neoplastic Cells 01/2024
1	Cardiotoxicity 12/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Adenocarcinoma 01/2019
1	Neuroblastoma 03/2015
1	Pancreatic Ductal Carcinoma 11/2014
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2014
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2013
1	Disease Progression 10/2013

Drug/Important Bio-Agent (IBA)

11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 03/2013
9	Gemcitabine FDA Link 01/2021 - 07/2014
9	EnzymesIBA 01/2019 - 08/2008
8	Peptides (Polypeptides)IBA 01/2023 - 01/2016
5	Oxygen (Dioxygen)IBA 11/2023 - 01/2016
5	PolymersIBA 01/2020 - 01/2012
5	Liposomes (Liposome)IBA 11/2014 - 07/2009
4	LipidsIBA 01/2022 - 07/2009
4	Drug CarriersIBA 01/2019 - 07/2014
4	Folic Acid (Vitamin M)FDA LinkGeneric 11/2016 - 03/2013
4	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2012
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2014 - 07/2009
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2014
3	IntegrinsIBA 01/2023 - 01/2022
3	Ethylene Glycol (Monoethylene Glycol)IBA 02/2022 - 01/2016
3	N-end cysteine peptide tumor-homing peptideIBA 01/2022 - 03/2018
3	LigandsIBA 10/2021 - 06/2013
3	poly(lactide) (polylactic acid)IBA 10/2021 - 01/2016
3	Culture MediaIBA 12/2012 - 01/2012
2	Histone Deacetylase InhibitorsIBA 05/2024 - 11/2013
2	Estrogen ReceptorsIBA 10/2021 - 11/2020
2	AminesIBA 12/2020 - 02/2019
2	napabucasinIBA 10/2018 - 03/2018
2	azobenzeneIBA 08/2018 - 01/2016
2	Histone Deacetylases (Histone Deacetylase)IBA 11/2016 - 11/2013
2	Coloring Agents (Dyes)IBA 01/2016 - 09/2012
2	Lipid NanoparticlesIBA 01/2016 - 11/2014
2	Matrix Metalloproteinases (MMPs)IBA 04/2011 - 08/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2024
1	entinostat (MS 275)IBA 05/2024
1	CelluloseIBA 01/2024
1	HydrogelsIBA 11/2023
1	aspartic acid glycine arginineIBA 02/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2022
1	NeuropilinsIBA 01/2022
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2021
1	4-hydroxy-N-desmethyltamoxifenIBA 10/2021
1	Tamoxifen FDA LinkGeneric 10/2021
1	BuffersIBA 01/2021
1	polycarbonateIBA 12/2020
1	pyrrolidineIBA 12/2020
1	AmidesIBA 12/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2020
1	Amino Acids FDA Link 06/2020
1	CollagenIBA 01/2020
1	Phosphotransferases (Kinase)IBA 09/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2019
1	HhAntag691IBA 02/2019
1	CarbonatesIBA 02/2019
1	Antineoplastic Agents (Antineoplastics)IBA 02/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Deoxycytidine KinaseIBA 01/2019
1	Connective Tissue Growth FactorIBA 01/2019
1	Reducing AgentsIBA 10/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2018
1	AcidsIBA 03/2018
1	Neuropilin-1IBA 03/2018
1	CurcuminIBA 01/2017
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2017
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2017
1	AntigensIBA 11/2016
1	mocetinostatIBA 11/2016
1	Docetaxel (Taxotere)FDA Link 11/2016
1	AndrogensIBA 11/2016
1	Acridine OrangeIBA 03/2016
1	Drug CombinationsIBA 03/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Membrane LipidsIBA 01/2016
1	N-(phenylcarbothiol)benzamideIBA 03/2015
1	DNA (Deoxyribonucleic Acid)IBA 11/2014
1	Small Interfering RNA (siRNA)IBA 11/2014
1	Vorinostat FDA Link 11/2013
1	DisintegrinsIBA 10/2013
1	Trastuzumab (Herceptin)FDA Link 06/2013
1	Receptor for Advanced Glycation End ProductsIBA 06/2013
1	human ERBB2 proteinIBA 06/2013

Therapy/Procedure

12	Therapeutics 05/2024 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2020 - 03/2018
1	Intravenous Injections 01/2023
1	Combination Drug Therapy (Combination Chemotherapy) 09/2019
1	Radiotherapy 08/2018
1	Intravenous Administration 07/2014